6-minute Walk Test in Cardiovascular Risk Assessment in Over 55-year-olds with Abdominal Obesity: Results of a One-Stage Outpatient Study
Abdominal obesity (AO) is associated with a high prevalence of cardiovascular risk factors and contributes to increased cardiovascular morbidity and mortality worldwide. The aim of this study was to assess the informative value of the 6-minute walk test in determining cardiovascular risk in persons over 55 years of age with abdominal obesity.
Subjects and methods: The study enrolled 70 patients, including 17 men (24 %) and 53 women (76 %) over 55 years of age. All subjects under study had collection of complaints and anamnesis, anthropometry, 6-minute walking test, biochemical blood tests for glucose, creatinine, lipoproteins and total cholesterol were performed, triplex scanning of brachiocephalic arteries, echocardiography, noninvasive angioscans on the diagnostic complex «AngioScan-01» were performed.
Results: All subjects were divided into 2 subgroups: with AO – 52 patients, and without it – 18 patients. Patients with AO had a greater number of conditions associated with increased risk of death from cardiovascular complications. Smoking, hyperglycemia, hypertriglyceridemia, general obesity, diabetes mellitus, arterial hypertension, coronary heart disease, and chronic kidney disease stage 3 were statistically significantly more common in them. The study showed that distance in the 6-minute walk test is decreased in patients with AO, and the decrease in this distance correlates with lower indices of endothelium-dependent vasodilation.
Conclusions: the 6-minute walk test is a simple functional test that can be used as an additional criterion of cardiovascular risk assessment in outpatient settings. Its determination is especially important in abdominal obese patients who are at high cardiovascular risk.
Mikhailova L.V., Sheleg D.O., Polyakova A.P., Voskoboynikova A.Y., Fedoseenko D.E. 2022. 6-minute Walk Test in Cardiovascular Risk Assessment in Over 55-year-olds with Abdominal Obesity: Results of a One-Stage Outpatient Study. 45 (3): 253–262 (in Russian). DOI: 10.52575/2687-0940-2022-45-3-253-262
While nobody left any comments to this publication.
You can be first.
Budnevskiy A.V., Kravchenko A.Ya., Tokmachev R.E., Chernik T.A., Tokmachev E.V., Letnikova Yu.B. 2020. Diagnosticheskie, prognosticheskie i terapevticheskie vozmozhnosti ispol'zovaniya testa 6-minutnoy khod'by u patsientov s khronicheskoy serdechnoy nedostatochnost'yu [Diagnostic, prognostic and therapeutic possibilities of using the test 6-minute walk in patients with chronic heart failure]. Kardiovaskulyarnaya terapiya i profilaktika. 19 (6): 109–116.
Klinicheskie rekomendatsii «Khronicheskaya serdechnaya nedostatochnost'» [Clinical guidelines «Chronic heart failure»] [Electronic resource]. 2020. Rossiyskoe kardiologicheskoe obshchestvo pri uchastii Natsional'nogo obshchestva po izucheniyu serdechnoy nedostatochnosti i zabolevaniy miokarda, Obshchestva spetsialistov po serdechnoy nedostatochnosti. S. 11–12.
Sorokina A.O. 2018. Komplaens patsientov s gipertonicheskoy bolezn'yu [Сompliance of patients with essential hypertension]. Ustoychivoe razvitie nauki i obrazovaniya. 5: 102–107.
Abraham T.M., Pedley A., Massaro J.M., Hoffmann U., Fox C.S. 2015. Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors. Circulation. 132 (17): 1639–1647.
Chylińska J., Łazarewicz M., Rzadkiewicz M., Adamus M., Jaworski M., Haugan G., Lillefjel M., Espnes G.A., Włodarczyk D. 2017. The role of gender in the active attitude toward treatment and health among older patients in primary health care-self-assessed health status and sociodemographic factors as moderators. BMC Geriatr. 17 (1): 284.
Fresiello L., Jacobs S., Timmermans P., Buys R., Hornikx M., Goetschalckx K., Droogne W., Meyns B. 2020. Limiting factors of peak and submaximal exercise capacity in LVAD patients. PLoS One. 9; 15 (7): e0235684. doi: 10.1371/journal.pone.0235684. eCollection 2020.
Giannitsi S., Bougiakli M., Bechlioulis A., Kotsia A., Michalis L.K., Naka K.K. 2019. 6-minute walking test: a useful tool in the management of heart failure patients. Ther Adv. Cardiovasc. Dis. 13:1753944719870084.
Gill T.M., DiPietro L., Krumholz H.M. 2000. Role of exercise stress testing and safety monitoring for older persons starting an exercise program. AMA The Journal of the American Medical Association. 3: 342–349.
Harb S.C., Wang T.K.M., Cremer P.C., Wu Y., Cho L., Menon V., Jaber W.A. 2021. Associations between cardiorespiratory fitness, sex and long term mortality amongst adults undergoing exercise treadmill testing. Int. J. Cardiol. 1 (342): 103–107.
Lenasi H., Novak A., Jug B., Dervišević E., Karpljuk D., Videmšek M., Sorić M., Hadžić. 2022. An Alternative Prediction Equation for Evaluation of Six-Minute Walk Distance in Stable Coronary Artery Disease Patients. Front. Physiol. 31 (13): 844–847.
Lipkin D.P., Scriven A.J., Crake T., Poole-Wilson P.A. 1986. Six minute walking test for assessing exercise capacity in chronic heart failure. Br. Med. J. (Clin. Res. Ed.). 8 (292): 6521–6535.
Matos Casano H.A., Anjum F. 2022. Six Minute Walk Test. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Jan–. PMID: 35015445
Nayak P., Guralnik J.M,. Polonsky T.S., Kibbe M.R., Tian L., Zhao L., Criqui M.H., Ferrucci L., Li L., Zhang D., McDermott M.M. 2020. Aug Association of six-minute walk distance with subsequent lower extremity events in peripheral artery disease. Vasc Med. 25 (4): 319–327.
Neeland I.J., Ross R., Després J.P., Matsuzawa Y., Yamashita S., Shai I., Seidell J., Magni P., Santos R.D., Arsenault B., Cuevas A., Hu F.B., Griffin B., Zambon A., Barter P., Fruchart J.C., Eckel R.H. 2019. International Atherosclerosis Society; International Chair on Cardiometabolic Risk Working Group on Visceral Obesity. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 10 pii: 10.1016/S2213-8587(19)30084-1.
Peeters P., Mets T. 1996. The 6-minute walk as an appropriate exercise test in elderly patients with chronic heart failure. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 4: M147–51.
Piché M.E., Poirier P., Lemieux I., Després J.P. 2018. Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update. Prog. Cardiovasc. Dis. 61 (2): 103–113.
Pou K.M., Massaro J.M., Hoffmann U., Vasan R.S., Maurovich-Horvat P., Larson M.G., Keaney J.F. Jr., Meigs J.B., Lipinska I., Kathiresan S., Murabito J.M., O'Donnell C.J., Benjamin E.J., Fox C.S. 2007. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: The framingham heart study. Circulation 116 (11): 1234–1241.
Rhee E.J. 2018. Being Metabolically Healthy, the Most Responsible Factor for Vascular Health. Diabetes Metab. J. 42 (1): 19–25.
Robert O. Crapo, Richard Casaburi, Allan L. Coates, Paul L. Enright, Neil R. Macintyre, Roy T. Mckay, Douglas Johnson, Jack S. Wanger, R. Jorge Zeballos. 2002. Clinical guidelines: American Thoracic Society statement: guidelines for the six-minute walk test. American Journal of Respiratory and Critical Care Medicine. 166 (1): 111–117.
Safdar B., Mangi A.A. 2020. Survival of the Fittest: Impact of Cardiorespiratory Fitness on Outcomes in Men and Women with Cardiovascular Disease. Clin. Ther. 42 (3): 385–392.
Stringer W., Marciniuk D. 2018. The Role of Cardiopulmonary Exercise Testing (CPET) in Pulmonary Rehabilitation (PR) of Chronic Obstructive Pulmonary Disease (COPD) Patients. COPD. 15 (6): 621–631. doi: 10.1080/15412555.2018.1550476.
Swiston J.R., Johnson S.R., Granton J.T. 2010. Factors that prognosticate mortality in idiopathic pulmonary arterial hypertension: a systematic review of the literature. Respir. Med. 104 (11): 1588–1607.